Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
TheFly reported on February 3 that Lake Street Capital Markets reduced its price target on AQST to $6 from $8 and maintained a Buy rating. This update followed the company's announcement that ...





